Countering the problem of falsified and substandard drugs

Detalles Bibliográficos
Autor principal:	Institute of Medicine (U.S.). (issuing body)
Autores Corporativos:	Institute of Medicine (U.S.). Committee on Understanding the Global Public Health Implications of Substandard, Falsified, and Counterfeit Medical Products, issuing body (issuing body), Institute of Medicine. Board on Global Health, issuing body
Otros Autores:	Buckley, Gillian J., editor (editor), Gostin, Lawrence O. (Lawrence Ogalthorpe), editor
Formato:	Libro electrónico
Idioma:	Inglés
Publicado:	Washington, District of Columbia : National Academies Press [2013]
Edición:	1st ed
Materias:	Pharmaceutical industry > Quality control. Fraud > Prevention.
Ver en Biblioteca Universitat Ramon Llull:	https://discovery.url.edu/permalink/34CSUC_URL/1im36ta/alma991009621949906719

Tabla de Contenidos:

""Front Matter""; ""Reviewers""; ""Acknowledgments""; ""Acronyms and Abbreviations""; ""Contents""; ""Boxes, Figures, and Tables""; ""Summary""; ""1 Introduction""; ""2 The Effects of Falsified and Substandard Drugs""; ""3 The Magnitude of the Problem""; ""4 Causes of Falsified and Substandard Drugs""; ""5 Weaknesses in the Drug Distribution Chain""; ""6 Detection Technology""; ""7 An International Code of Practice for Falsified and Substandard Medicines""; ""Appendix A: Glossary""; ""Appendix B: Committee Biographies""; ""Appendix C: Meeting Agendas""

Ejemplares similares